Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Por M.P. Lux, C. Minartz, H. Müller-Huesmann, M.F. Sandor, K.H. Herrmann, S. Radeck-Knorre, A.S. Neubauer
Publicado em 2022-01-01